Results 91 to 100 of about 412,323 (297)

Quantitative proteomic analysis reveals different characteristics of bladder cancer cells after exposure to bisphenol A

open access: yesFEBS Open Bio, EarlyView.
Bisphenol A (BPA), a common chemical in plastics, exerts dual effects on bladder cancer cells: low doses promote growth and migration, while high doses suppress growth and migration. Multi‐omics and bioinformatics reveal BPA acts via MAPK and inflammatory pathways.
Shaomin Niu   +10 more
wiley   +1 more source

Predicting and Comparing the Subjective Health Experience of Older Cancer Survivors and Non‐Cancer Survivors: A Modeling Approach

open access: yesAging and Cancer, EarlyView.
This study underscores the significant influence of frailty and vitality on the subjective health experience of older cancer survivors with acceptance and control emerging as salient mediators. These findings affirm the conceptual and empirical robustness of the model highlighting its potential utility in shaping future interventions for older cancer ...
Damien S. E. Broekharst   +4 more
wiley   +1 more source

May 2021 ERA Update [PDF]

open access: yes, 2021
The campaign to finalize the Equal Rights Amendment is being waged on several fronts. One in the courts, one in Congress. Last week, there were developments in two important lawsuits seeking to have the Equal Rights Amendment declared finalized and a ...
Center for Gender and Sexuality Law,
core   +1 more source

Prognostic Impact of European LeukemiaNet Genetic Risk Stratification System in Adult Patients With Acute Myeloid Leukemia

open access: yesAging and Cancer, EarlyView.
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha   +4 more
wiley   +1 more source

Columbia Law School ERA Project FAQ on Legal Issues Surrounding Final Ratification of the Equal Rights Amendment [PDF]

open access: yes, 2021
New York, New York – On March 17, 2021, the House of Representatives has scheduled a vote on House Joint Resolution 17, a measure that would remove any deadline for ratification of the Equal Rights Amendment (ERA) and, as a consequence, would make the ...
Center for Gender and Sexuality Law,
core   +1 more source

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham   +7 more
wiley   +1 more source

WGS: This is What a WGS Student/Alumni Looks Like [PDF]

open access: yes, 2014
Promotional piece for a presentation by Nicolle Littrell, filmmaker and instructor who previewed selections from a new video campaign she produced for the University of Maine Women\u27s, Gender, and Sexuality Studies ...
Women\u27s, Gender, and Sexuality Studies
core   +1 more source

An overview of research on gender in Spanish society [PDF]

open access: yes, 2002
This article presents an overview of research on gender in Spanish society. Six areas of literature are examined including families, education, work, politics, sexuality, and men.
Valiente Fernández, Celia
core   +3 more sources

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks   +10 more
wiley   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy